Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Yen-Hsia Wen"'
Autor:
Hong-Ren Yu, Jui-Hsiu Tsai, Chun-Hung Richard Lin, Jiu-Yao Wang, Yen-Hsia Wen, Shihn-Sheng Wu, Yuan Hou, Ing-Kit Lee, Hung-Pin Tu, Yi-Chen Lee
Publikováno v:
Allergology International, Vol 68, Iss 4, Pp 486-493 (2019)
Background: Dengue fever (DF) is the most rapidly spreading mosquito-borne viral disease. Practical vaccines or specific therapeutics are still expected. Environmental factors and genetic factors affect the susceptibility of Dengue virus (DV) infecti
Externí odkaz:
https://doaj.org/article/c3167b03707f4d249145dae95cd1c6cc
Autor:
Yueh-Lung Peng, Chien-Te Lee, You-Lin Tain, Yaw-Bin Huang, Hung-Yi Chuang, Yen-Hsia Wen, Shiou-Huei Huang, Chun-Yu Tsai, Chien-Ning Hsu
Publikováno v:
PLoS ONE, Vol 14, Iss 8, p e0221504 (2019)
ObjectivesChanges in treatment choice of therapy and size of treated population that can lead to under- or overestimate of payer's budget are less likely to be reassured after reimbursement adoption of a new drug. The aim of this study was to evaluat
Externí odkaz:
https://doaj.org/article/ab0533d12e6a4d579a0833e4975cde36
Autor:
Ching-Ying Wu, Hsin-Su Yu, Chee-Yin Chai, Yen-Hsia Wen, Shihn-Sheng Wu, Yang-Pei Chang, Chun-Hung Richard Lin, Jui-Hsiu Tsai
Publikováno v:
PLoS ONE, Vol 14, Iss 6, p e0218652 (2019)
BackgroundBehçet's disease (BD) is a recurrent, multisystemic, inflammatory disorder that mainly affects blood vessels. Because recurrent inflammation of blood vessels in the brain plays a crucial role in the development of ischemic stroke, we hypot
Externí odkaz:
https://doaj.org/article/11ccf0b729fb460ca1cfe34fcf1ab01e
Autor:
Meng-Ju Chan, Yaw-Bin Huang, Yen-Hsia Wen, Hung-Yi Chuang, You-Lin Tain, Yu-Ching Lily Wang, Chien-Ning Hsu
Publikováno v:
Journal of the Formosan Medical Association, Vol 115, Iss 2, Pp 83-93 (2016)
A risk management plan (RMP) was introduced to monitor the association between initiation of antitumor necrosis factor-α (anti-TNF-α) therapy and tuberculosis (TB) and viral hepatitis infections. The aim of this study was to assess adherence and pr
Externí odkaz:
https://doaj.org/article/9197530bd3a245f3a2395f49c06a2fa0
Autor:
Wen-Hung Chung, Hung-Yi Chuang, You-Lin Tain, Chien-Ning Hsu, Yaw-Bin Huang, Yen-Hsia Wen, Ching-Hua Ke
Publikováno v:
Pharmacogenetics and Genomics. 29:1-8
Aim Human leukocyte antigen (HLA-B*58:01) allele screening before allopurinol administration is recommended to prevent gene-mediated severe cutaneous adverse reactions (SCARs). The objective of the analysis was to examine the clinical utility and eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd72ad600128c33339989b3553352088
https://doi.org/10.1097/fpc.0000000000000359
https://doi.org/10.1097/fpc.0000000000000359
Publikováno v:
Journal of Food and Drug Analysis. 10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b366e270a20889d422a4feba35606951
https://doi.org/10.38212/2224-6614.2757
https://doi.org/10.38212/2224-6614.2757
Publikováno v:
Journal of Food and Drug Analysis. 17
A reversed-phase liquid chromatography with ultraviolet detection is described for the determination of cotinine. A mobile phase consisted of an acetate buffer with sodium octanesulfonate as an ion pair reagent and methanol was used to resolve cotini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d81cc77d4f66e96afb18b930f97d9f07
https://doi.org/10.38212/2224-6614.2589
https://doi.org/10.38212/2224-6614.2589
Autor:
Yi-Hsn Yang, Yueh-Lung Peng, Chien-Ning Hsu, Chien-Te Lee, Yaw-Bin Huang, You-Lin Tain, Yen-Hsia Wen
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
Whether the clinical trial treatment effect of urate-lowering therapy (ULT) in patient with chronic kidney disease (CKD) is generalizable to real-word settings is unclear. This study aimed to compare febuxostat with allopurinol for uric acid reductio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87b9d67a38249f71e802813af65c4747
https://pubmed.ncbi.nlm.nih.gov/32612180
https://pubmed.ncbi.nlm.nih.gov/32612180
Autor:
M.‐J. Chan, Hung-Yi Chuang, Y.‐B. Huang, Yen-Hsia Wen, C.‐N. Hsu, You-Lin Tain, Y.‐C. Lily Wang
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 43:256-264
SummaryWhat is known and objective Patients with rheumatic disease are at risk for infections. Evaluating antitumour necrosis factor (anti-TNF) drug-associated risk of infections requires justification of baseline risk in the population at high risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07420e0b1556cb60c1f362e217d48df7
https://doi.org/10.1111/jcpt.12644
https://doi.org/10.1111/jcpt.12644
Autor:
Hung-Yi Chuang, Chun-Yu Tsai, Yen-Hsia Wen, Chien-Te Lee, Yaw-Bin Huang, You-Lin Tain, Yueh-Lung Peng, Chien-Ning Hsu, Shiou-Huei Huang
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 8, p e0221504 (2019)
PLoS ONE, Vol 14, Iss 8, p e0221504 (2019)
ObjectivesChanges in treatment choice of therapy and size of treated population that can lead to under- or overestimate of payer's budget are less likely to be reassured after reimbursement adoption of a new drug. The aim of this study was to evaluat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cddb1cc559a8423b0ede19e191320c31
http://europepmc.org/articles/PMC6709886
http://europepmc.org/articles/PMC6709886